Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 15, 2017 11:55 ET | Source: Biodesix, Inc.

Interim Results from Biodesix® Study Indicate That VeriStrat Testing Impacts Treatment Decisions Across All Stages of Non-Small Cell Lung Cancer

BOULDER, Colo., Sept. 15, 2017 (GLOBE NEWSWIRE) -- Interim analysis of a new study examining the impact of VeriStrat testing on treatment decisions in patients with non-small cell lung cancer...
August 08, 2017 13:17 ET | Source: Biodesix, Inc.

Biodesix Presents Cell-free DNA Process Optimization for Liquid Biopsy Test

BOULDER, Colo., Aug. 08, 2017 (GLOBE NEWSWIRE) -- In two separate talks, Biodesix scientists presented information on further development and improvement of laboratory processes used for the...
July 10, 2017 13:09 ET | Source: Biodesix, Inc.

Lung Cancer: VeriStrat® Test Identifies Patients with Squamous Cell Carcinoma of the Lung Who Are More Likely to Have Improved Survival on Afatinib Therapy

BOULDER, Colo., July 10, 2017 (GLOBE NEWSWIRE) -- Clinical findings published in the peer reviewed journal Lung Cancer show that the Biodesix® VeriStrat test is prognostic for outcomes in patients...
June 12, 2017 12:37 ET | Source: Biodesix, Inc.

Biodesix® and Positive Bioscience Announce Partnership to Bring Cancer Tests to India

BOULDER, Colo., June 12, 2017 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Boulder, CO, USA) and Positive Bioscience (Mumbai, India) announced today that they have entered into an agreement where Positive...
May 22, 2017 13:31 ET | Source: Biodesix, Inc.

New Study Shows Advanced Diagnostic Tests, Including the VeriStrat® Test, Can Help Physicians Improve Cancer Care Planning and Reach Quality Measures For Patients

BOULDER, Colo., May 22, 2017 (GLOBE NEWSWIRE) -- Today, Biodesix®, Inc. will present the results of a new study demonstrating that VeriStrat testing and other tools can help physicians improve...
April 05, 2017 08:00 ET | Source: Biodesix, Inc.

Biodesix Presents Data From Three Studies at AACR Annual Meeting

BOULDER, Colo., April 05, 2017 (GLOBE NEWSWIRE) -- Biodesix is presenting three studies that support the company’s multi-omic capabilities and provide insight into the biology of classifiers...
April 03, 2017 13:08 ET | Source: Biodesix, Inc.

New Data Show Biodesix’s VeriStrat® Test is Cost-Saving, Improves Survival and Quality of Life in Advanced Lung-Cancer Patients

BOULDER, Colo., April 03, 2017 (GLOBE NEWSWIRE) -- Biodesix®, Inc. announced today new data demonstrating that use of the VeriStrat® test in patients with advanced non-small cell lung cancer (NSCLC)...
March 22, 2017 14:03 ET | Source: Biodesix

New Study Shows Biodesix’s VeriStrat Changes Treatment Decisions for Lung Cancer Patients; Reduces Over-Treatment at End of Life

BOULDER, Colo., March 22, 2017 (GLOBE NEWSWIRE) -- Biodesix®, Inc. announced today the results of a study demonstrating that the use of the VeriStrat® test for patients with non-small cell lung...
March 20, 2017 12:14 ET | Source: Biodesix

Study Results from Biodesix’s Immunotherapy Test Will Be Presented by Dr. Jeffrey Weber

BOULDER, Colo., March 20, 2017 (GLOBE NEWSWIRE) -- Dr. Jeffery Weber will present data from a collaboration in which proteomic tests developed by Biodesix® could help guide therapy choices in...
March 09, 2017 10:30 ET | Source: Biodesix

Biodesix® and Progenetics Announce Distribution Agreement for Israel

BOULDER, Colo., March 09, 2017 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Boulder, CO, USA) and Progenetics LTD (Tel Aviv, Israel) announced today that they have entered into an international agreement...

keyboard_arrow_left Previous Page